artemether and paclitaxel
artemether has been researched along with paclitaxel in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Dembitsky, VM | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Emami, SA; Taleghani, A; Tayarani-Najaran, Z | 1 |
Ju, RJ; Li, XT; Li, XY; Lou, JN; Lu, WL; Mu, LM; Shi, JF; Sun, MG; Zeng, F; Zhang, CX; Zhao, WY; Zhao, Y | 1 |
Badanthadka, M; Chokshi, N; Khatri, H; Patel, BM; Patel, MM; Rawal, S | 1 |
Duan, X; Li, Q; Li, X; Li, Y; Shi, L; Wang, Y | 1 |
Reviews
2 review(s) available for artemether and paclitaxel
Article | Year |
---|---|
Bioactive peroxides as potential therapeutic agents.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Peroxides | 2008 |
Artemisia: a promising plant for the treatment of cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisia; Cell Proliferation; Humans; Molecular Structure; Neoplasms; Neoplasms, Experimental; Plant Extracts; Plants, Medicinal | 2020 |
Other Studies
4 other study(ies) available for artemether and paclitaxel
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemether; Artemisinins; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Dequalinium; Drug Delivery Systems; Glioma; Liposomes; Male; Mannose; Mice; Mice, Inbred ICR; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Vitamin E | 2014 |
Fabrication and in vivo evaluation of ligand appended paclitaxel and artemether loaded lipid nanoparticulate systems for the treatment of NSCLC: A nanoparticle assisted combination oncotherapy.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Artemether; Biological Availability; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Folic Acid; Humans; Lipids; Lung Neoplasms; Male; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polyethylene Glycols; Rats, Sprague-Dawley; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
The enhanced treatment efficacy of invasive brain glioma by dual-targeted artemether plus paclitaxel micelles.
Topics: Animals; Artemether; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Interactions; Glioma; Mice; Mice, Inbred ICR; Micelles; Molecular Targeted Therapy; Neoplasm Invasiveness; Paclitaxel | 2020 |